Licks Attorneys' Government Affairs & International Relations Blog

A agência norte-americana Food and Drug Administration (FDA) acaba de publicar um novo guia com orientações para fabricantes a respeito da escolha de nomes para seus medicamentos, sempre com foco na confiança e distinção dos demais medicamentos, transmitidas aos usuários finais, ou seja, aos pacientes.

‍

The US Food and Drug Administration (FDA) has just published new guidelines for manufacturers regarding the choice of names for their medicines. The guide focuses on how the trust and distinction of other existing medication may be transmitted to end-users, that is, to patients.

‍

A Pfizer Inc. ajuizou um processo em 26 de junho de 2020, segundo a Reuters, para exigir que o governo federal a permita ajudar os beneficiários do programa federal de saúde Medicare a pagar dois medicamentos para tratar uma doença cardíaca rara e às vezes fatal, e que custam US$ 225.000 por ano.

‍

According to Reuters, Pfizer Inc. filed a lawsuit on June 26, 2020, to make it possible to help beneficiaries of the federal healthcare program - Medicare - pay for two drugs to treat a rare and sometimes fatal heart disease, and that cost $225,000 a year.

‍

On June 12th, a debate about the “Importance of governmental politics on industrial property to fight against the negative impacts of agrobusiness”, requested by Senator Lasier Martins (Podemos/RS), was organized in the Senate by the Commission of Agriculture and Agrarian reform (CRA).